| Ms Gabriella C Buchnik, CCC-SLP | |
|
10303 N Port Washington Rd, Suite 203, Mequon, WI 53092-5760 | |
| (262) 241-5955 | |
| (262) 241-5926 |
| Full Name | Ms Gabriella C Buchnik |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 10303 N Port Washington Rd, Mequon, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154528172 | NPI | - | NPPES |
| 235Z00000X | Other | WI | SPEECH PATHOLOGIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2923-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Gabriella C Buchnik, CCC-SLP 1845 W Wayside Dr, Glendale, WI 53209-2186 Ph: (414) 540-1528 | Ms Gabriella C Buchnik, CCC-SLP 10303 N Port Washington Rd, Suite 203, Mequon, WI 53092-5760 Ph: (262) 241-5955 |
News Archive
PROLOR Biotech, Inc., today announced that it has entered into a definitive license agreement with Yeda Research and Development Company Ltd. for novel technology utilized in the development of long-acting therapeutic peptides and small molecules, termed Reversible PEGylation.
As part of a collaborative initiative, PLOS and the Drugs for Neglected Diseases initiative (DNDi) are delighted to be launching a special Collection-PLOS & DNDi: a decade of Open Access and Neglected Tropical Diseases R&D (Research and Development)-to coincide with a joint event at the Institut Pasteur in Paris celebrating the 10-year anniversary of DNDi.
A simple and cost effective imaging device for breast tumor detection based on a flexible and wearable antenna system has been developed by researchers at the Indiana University - Purdue University Indianapolis.
New research published in Molecular Oncology may help explain why African American men are at a higher risk of being diagnosed with prostate cancer and a higher risk of dying from the disease compared with European American men.
Shire plc, the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company. Movetis is listed on Euronext and focuses on discovering, developing and commercializing innovative treatments for GI conditions with a high unmet medical need.
› Verified 9 days ago
Mrs. Kim Ann Glaser, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 13111 N Port Washington Rd, Mequon, WI 53097 Phone: 262-243-5757 | |
Michelle Rivera, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 403 W Mequon Rd, Mequon, WI 53092 Phone: 262-643-4771 | |
Bloom Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1017 W Glen Oaks Ln Ste 140, Mequon, WI 53092 Phone: 414-533-8050 | |
Mrs. Cindy Schultz Katzoff, M.A. SLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10995 N Market St, Mequon, WI 53092 Phone: 262-478-1581 | |
Milagros Caceres, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12600 Pt. Washington Rd, Newcastle Place, Mequon, WI 53092 Phone: 262-387-8800 | |
Emily Smith, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1486 W Mequon Rd, Mequon, WI 53092 Phone: 262-241-8030 |